C9orf72 六核酸重复扩张损害了ALS中的微质反应
Pegah Masrori1,2,3, Baukje Bijnens4,5, Laura Fumagalli4,5
1KU Leuven - University of Leuven, Department of Neurosciences, Laboratory of Neurobiology and Leuven Brain Institute (LBI), Leuven, Belgium. pegah.masrori@kuleuven.be.
Nature neuroscience
|October 14, 2025
概括
零星ALS微质变得与疾病相关,而C9orf72ALS微质表现出减少的反应. 这揭示了ALS亚型中独特的细胞机制,影响了治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
背景情况:
- 微细胞和神经炎症与肌缩性侧面硬化症 (ALS) 有关.
- 驱动ALS病变的特定分子机制,特别是不同的遗传形式,仍然不清楚.
- C9orf72突变是遗传ALS的一个常见原因.
研究的目的:
- 研究微质在散发性ALS (sALS) 与C9orf72相关的ALS (C9-ALS) 之间的显著分子和细胞反应.
- 阐明C9orf72六核酸重复扩张 (HRE) 在微质功能和反应中的作用.
- 通过了解ALS的亚型特异性细胞变化来确定潜在的治疗点.
主要方法:
- 从sALS和C9-ALS患者的脊髓和运动皮质的单核RNA测序.
- 人类微质异种移植模型评估C9orf72突变对微质激活的影响.
- 诱导多能干细胞 (iPSC) 衍生微质细胞,以确认内分泌体路径的改变.
- 对微质细胞和星体细胞中的星体细胞反应和体受体相互作用的分析.
主要成果:
- C9orf72在微质中表达很高,其HRE导致了哈普隆不充足.
- sALS微质体采用与疾病相关的状态,而C9-ALS微质体则表现出具有内分泌体通路失调的模糊反应.
- 在异种移植和iPSC模型中,C9orf72突变降低了微质激活.
- C9orf72 HRE天体细胞也表现出减少的反应,在两种细胞类型中都发现了失调的连接体-受体对.
结论:
- 不同的细胞基质是零星和C9orf72相关的ALS的基础.
- 缺乏C9orf72会损害微质细胞和星球细胞的反应,从而导致ALS的发病.
- 这些发现对患者分层和ALS个性化治疗方法有重大影响.
相关概念视频
Cross-bridge Cycle
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...


